Summary
Build Your Brand is an FDA-registered, GMP-certified contract manufacturer specializing in berberine GLP-1 supplements and private label berberine GLP-1 supplement products. Based in the USA with over 17 years of experience and 500+ brands served, we offer turnkey manufacturing from custom formulation through packaging and fulfillment. Our facility maintains NSF International certification and all products undergo third-party testing through ISO 17025 accredited laboratories.
Services
- Custom formulation and product development for berberine GLP-1 supplement products
- Low minimum order quantities starting at 300 units
- Third-party laboratory testing for potency, purity, and safety
- Full packaging design, label compliance, and fulfillment services
- Amazon FBA prep and direct-to-consumer shipping
Frequently Asked Questions
What is the legal status of "natural Ozempic" positioning?
The phrase "natural Ozempic" is a marketing-claim minefield. Ozempic is a registered trademark (Novo Nordisk), and any direct comparison or alternative claim against a prescription drug is treated by the FDA as an unauthorized drug claim under DSHEA section 403(r)(6). We help brands frame the positioning legally: defensible structure-function language includes "blood sugar support," "healthy glucose metabolism," "AMPK activation," "natural metabolic support," "GLP-1 lifestyle support" (the last only with care). Phrases to avoid: "replaces Ozempic," "natural semaglutide," "treats type 2 diabetes," "causes weight loss." Our regulatory team reviews every claim before artwork ships, and we update the safe-claim playbook quarterly as FTC enforcement priorities evolve.
Why liposomal berberine instead of standard berberine HCl?
Unencapsulated berberine HCl has approximately 5 percent oral bioavailability (the well-published limit that constrains commodity-berberine product efficacy). Liposomal berberine (phospholipid-encapsulated 500mg per cap) increases absorption meaningfully and creates a defensible product narrative that justifies a premium price point and a differentiated shelf story. Most B2B PL competitors still ship unencapsulated commodity berberine; the liposomal lane is where the educated post-GLP-1-discontinuation buyer is shifting. We stock both: liposomal for premium SKUs, standardized HCl with piperine (BioPerine) co-activation for volume SKUs.
Why bitter melon and Ceylon cinnamon in the stack?
Bitter melon (Momordica charantia) is the single most-evidence-backed natural ingredient for blood-sugar postprandial response, working via charantin (a steroid saponin), polypeptide-p (a plant insulin analog), and vicine. We source charantin-standardized to 10 percent on every batch. Ceylon cinnamon (Cinnamomum verum, the true cinnamon, not cassia) supports insulin sensitivity through methylhydroxychalcone polymers and has the largest body of published human glucose-response data. We specifically use Ceylon, not cassia, because cassia contains coumarin levels that fail the chronic-use hepatic and renal safety threshold (cassia has approximately 1,250x more coumarin than Ceylon).
What other ingredients stack with berberine?
The most evidence-backed berberine stack partners are bitter melon (Momordica charantia, charantin-standardized for postprandial response), Ceylon cinnamon (Cinnamomum verum, glucose sensitivity), chromium picolinate (200mcg, insulin signaling), gymnema sylvestre (400mg, sweet-taste suppression and cravings reduction), alpha-lipoic acid (300mg, insulin signaling and antioxidant), myo / d-chiro inositol (2g at 40:1 ratio, metabolic syndrome and PCOS positioning), and milk thistle (silymarin, hepatic-load co-actor since berberine is liver-metabolized). For GLP-1 discontinuation specifically, add high-bioavailability protein and B-vitamins to support lean-mass preservation and energy metabolism during the transition off the medication. We formulate custom stacks dosed at clinically-meaningful levels.
MOQ and lead time for the GLP-1 companion stack?
Gummy formats start at 500 units per SKU for stock formulations with custom labeling. Capsule formats start at 3,000 units (the format that suits the clinical 500mg liposomal dose). Stock formulations ship in 3 to 4 weeks with approved artwork. Custom formulations (new stack ratios, novel co-actives, branded-ingredient sourcing) require 4 to 6 weeks from approved formula. First orders should allow 8 to 10 weeks from inquiry to finished goods to account for sampling, artwork, regulatory review, and shipping. Payment terms are 50 / 50: 50 percent deposit at quote acceptance, 50 percent before shipping.
What about side effects, contraindications, and label warnings?
Berberine has a well-documented safety profile at clinical doses (500 to 1,500mg per day in published trials), but specific cautions belong on every label: not for pregnancy or nursing (uterotonic activity), not for infants (jaundice risk), interactions with cyclosporine and other CYP3A4 substrates, and a transient GI side-effect profile (loose stool, cramping) that resolves with dose titration. Berberine should not be combined with metformin or active GLP-1 medication without medical supervision (additive blood-sugar lowering). Our regulatory team includes the appropriate caution language on every berberine product label, mapped to the latest FDA caution database and FTC enforcement patterns.
- Liposomal Berberine Dose
- 500mg
- MOQ Units (Gummies)
- 500
- 6-Month Capture Window
- BREAKOUT
- Production Timeline
- 4-6 wk
Private Label Berberine GLP-1 Stack Manufacturing
Berberine is the breakout GLP-1 companion ingredient of 2026, and the timing is precise. The FDA stopped allowing compounding pharmacies to sell affordable semaglutide and tirzepatide knockoffs in April 2026 (the 503B shortage list removal), and a substantial share of the 25-million-American GLP-1 user base is now actively looking for natural alternatives and post-discontinuation maintenance protocols. Berberine HCl, a quaternary ammonium alkaloid extracted from Berberis aristata (Indian barberry) and Coptis chinensis (goldthread), is the single most clinically-studied natural ingredient that activates the AMPK metabolic pathway (the same pathway metformin works through) and has earned the viral "natural Ozempic" positioning across TikTok, Reddit, and the wider GLP-1 discontinuation community. Search demand: 106 impressions per 90 days at GSC position 8.4 already, ahead of the FDA restriction cycle taking full effect. The 6-month capture window for B2B PL manufacturers is open and the competition is still thin.
Our berberine GLP-1 manufacturing program centers on a defensible, evidence-backed stack architecture rather than commodity berberine HCl. The flagship SKU is liposomal berberine 500mg + bitter melon (Momordica charantia) 200mg standardized to 10 percent charantin + Ceylon cinnamon (Cinnamomum verum) 1g. The liposomal delivery system (phospholipid-encapsulated berberine HCl) addresses the meaningful bioavailability ceiling of unencapsulated berberine (which is around 5 percent oral bioavailability), and Agent7 GSC data shows "liposomal berberine" is a position-99 thin-content query no competitor has captured yet. Bitter melon and Ceylon cinnamon are the two most-evidence-backed natural co-actives for blood sugar and metabolic positioning, and the stack mirrors the structure of the highest-performing GLP-1-adjacent DTC brands (without naming them) while opening the B2B PL lane that DTC dominates today.
Whether you are launching a standalone berberine HCl SKU for blood-sugar-curious shoppers, building a full GLP-1 companion line for the post-503B discontinuation market, or anchoring a metabolic-health stack around the natural-Ozempic positioning, our private label partnership delivers the formulation depth, regulatory review, and production flexibility to capture the breakout window. Every batch is produced in our FDA-registered, cGMP-certified facility under 21 CFR Part 111, with HPLC verification of berberine HCl content, charantin standardization on the bitter melon, and coumarin screening on the Ceylon cinnamon (Ceylon is the low-coumarin safe form, not cassia, which fails the chronic-use safety threshold for hepatic and renal load). Regulatory review on every claim ensures your launch stays on the structure-function side of the FDA / FTC line: blood sugar support and healthy metabolism are defensible, weight loss and disease treatment are not.
Our Manufacturing Process
From initial concept to finished product, every step is managed under one roof with dedicated quality oversight and transparent communication.
Liposomal Berberine Formulation and Bioavailability Strategy
Unencapsulated berberine HCl has approximately 5 percent oral bioavailability, the published bottleneck that limits product efficacy and shelf differentiation. Liposomal berberine (phospholipid-encapsulated 500mg per cap) is the bioavailability story that justifies a premium price point and a defensible product narrative. We formulate around the liposomal anchor or, for volume-priced SKUs, standardized berberine HCl with piperine (BioPerine) co-activation. Cost per dose modeled across both strategies before production.
Natural GLP-1 Stack Architecture (Berberine + Bitter Melon + Ceylon Cinnamon)
The flagship stack is 500mg liposomal berberine + 200mg bitter melon (charantin-standardized 10 percent) + 1g Ceylon cinnamon (low-coumarin, the safe long-use form). Optional extensions: chromium picolinate 200mcg (insulin sensitivity), gymnema sylvestre 400mg (sweet-taste suppression for cravings), alpha-lipoic acid 300mg (insulin signaling), and inositol 2g (myo / d-chiro 40:1 ratio for metabolic syndrome). We model cost per dose across each extension before production. Capsule MOQ 3,000, gummy MOQ 500.
21 CFR Part 111 Production with Active-Standardization Verification
Manufactured in our FDA-registered, cGMP-certified facility under 21 CFR Part 111. Every batch undergoes HPLC verification of berberine HCl content (97 percent purity standard), charantin standardization on the bitter melon (10 percent active marker), coumarin screening on the Ceylon cinnamon (must stay below the toxic-hepatic threshold that cassia cinnamon fails), heavy-metal screening, microbiological analysis, and stability validation. Per-batch COA ships with every order. The credentials that differentiate from commodity berberine on Amazon.
FTC and FDA Claims Review (GLP-1 Adjacency Without Crossing the Line)
GLP-1-adjacent positioning is a regulatory minefield. We help your copy frame the natural-Ozempic positioning legally: blood sugar support, healthy metabolism, AMPK activation are defensible structure-function claims under DSHEA. Treats diabetes, replaces semaglutide, causes weight loss are unauthorized drug claims that trigger FDA warning letters and FTC enforcement. The regulatory team reviews every claim, landing page, and Amazon listing before artwork ships. We also flag any claims that overlap with active FDA enforcement priorities (the post-503B compounding-pharmacy restrictions create heightened scrutiny on natural alternatives in 2026).
Key Benefits for Your Brand
Every aspect of our berberine GLP-1 supplements manufacturing is designed to accelerate your time-to-market while maintaining uncompromising quality standards.
Liposomal Berberine 500mg: The Bioavailability Story
Unencapsulated berberine HCl has approximately 5 percent oral bioavailability. Liposomal berberine (phospholipid-encapsulated 500mg per cap) addresses the bottleneck and creates a defensible product narrative with a premium price point. Agent7 GSC data shows "liposomal berberine" is a position-99 thin-content query no B2B competitor has captured yet. The 6 to 12 month window before the lane saturates is your capture opportunity.
BREAKOUT Timing: Post-FDA-503B GLP-1 Discontinuation Market
The FDA removed compounded semaglutide and tirzepatide from the 503B shortage list in April 2026, ending affordable compounding-pharmacy access for a large share of the 25-million-American GLP-1 user base. The post-discontinuation natural-alternative market is opening now, the search demand is climbing, and B2B PL competitors have not built dedicated pages yet. The bank explicitly tags this as a 6-month capture window.
Evidence-Backed Stack Architecture (Not Commodity Berberine)
The flagship 500mg liposomal berberine + 200mg bitter melon + 1g Ceylon cinnamon stack is built around the three natural ingredients with the strongest published evidence for AMPK activation, insulin sensitivity, and blood-sugar postprandial response. The stack mirrors the structure of the highest-performing GLP-1-adjacent DTC brands, ready to be private-labeled into your retail or Amazon line.
Ceylon (Not Cassia) Cinnamon: The Safe Long-Use Form
Cassia cinnamon (the cheap mass-market form) contains coumarin levels that fail the chronic-use hepatic and renal safety threshold. Ceylon cinnamon (Cinnamomum verum, the true cinnamon) has approximately 1,250x less coumarin and is the only form safe for daily long-term GLP-1-companion positioning. We source Ceylon-verified with coumarin screening on every batch.
FTC-Compliant Claims Review and Per-Batch COA
Natural-Ozempic positioning is a regulatory minefield. Our team reviews every claim across labels, landing pages, and Amazon listings to keep your brand on the structure-function side of the FDA / FTC line (blood sugar support and healthy metabolism: defensible; treats diabetes or replaces semaglutide: not). Per-batch COA includes berberine HCl HPLC verification, charantin standardization, coumarin screening, heavy metals, and microbiology.
Frequently Asked Questions
Common questions about our berberine GLP-1 supplements private label manufacturing services.
Explore More Manufacturing Services
Berberine Supplements
Berberine HCl capsules - metabolic health, blood sugar support, and weight management.
Learn moreWeight Loss Supplements
Diet pills, fat burners & appetite suppressants with clinically studied ingredients.
Learn moreDietary Fiber Supplements
Glucomannan, psyllium & soluble fiber - EU-approved weight loss claim ingredients.
Learn moreCreatine Supplements
Creatine monohydrate powders and capsules - sports performance and cognitive support.
Learn moreReady to scale your product line?
Speak with an account executive today to discuss your next run of berberine GLP-1 supplements.